{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T22:17:29Z","timestamp":1793657849093,"version":"4.5.1"},"reference-count":21,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T00:00:00Z","timestamp":1762387200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008171","name":"Minneapolis Heart Institute Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008171","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","heartrhythmopen.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart Rhythm O2"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.hroo.2025.11.002","type":"journal-article","created":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T10:33:29Z","timestamp":1763030009000},"page":"293-298","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Inappropriate shocks from subcutaneous and transvenous implantable cardioverter-defibrillators: Reports from the FDA MAUDE database"],"prefix":"10.1016","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9172-1089","authenticated-orcid":false,"given":"Robert G.","family":"Hauser","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariam","family":"Desouki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larissa I.","family":"Stanberry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerollos","family":"Abdelsayed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"Kapphahn-Bergs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawn","family":"Witt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay N.","family":"Sengupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hroo.2025.11.002_bib1","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1056\/NEJMoa013474","article-title":"Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction","volume":"346","author":"Moss","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hroo.2025.11.002_bib2","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1056\/NEJMoa043399","article-title":"Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure","volume":"352","author":"Bardy","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hroo.2025.11.002_bib3","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1056\/NEJMoa0909545","article-title":"An entirely subcutaneous implantable cardioverter-defibrillator","volume":"363","author":"Bardy","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hroo.2025.11.002_bib4","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1161\/CIRCEP.108.834093","article-title":"Risk of failure of transvenous implantable cardioverter-defibrillator leads","volume":"2","author":"Borleffs","year":"2009","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hroo.2025.11.002_bib5","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1056\/NEJMoa1915932","article-title":"Subcutaneous or transvenous defibrillator therapy","volume":"383","author":"Knops","year":"2020","journal-title":"N Eng J Med"},{"key":"10.1016\/j.hroo.2025.11.002_bib6","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.7326\/M22-1566","article-title":"Perioperative safety and early patient and device outcomes among subcutaneous versus transvenous implantable cardioverter defibrillator implantation","volume":"175","author":"Healey","year":"2022","journal-title":"Ann Int Med"},{"key":"10.1016\/j.hroo.2025.11.002_bib7","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1093\/eurheartj\/ehu112","article-title":"Worldwide experience with a totally subcutaneous implantable defibrillator: early results from the EFFORTLESS S-ICD Registry","volume":"35","author":"Lambiase","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hroo.2025.11.002_bib9","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.hroo.2025.05.033","article-title":"Safety of a pacemaker mode intended to protect patients","volume":"6","author":"Hauser","year":"2025","journal-title":"Heart Rhythm O2"},{"key":"10.1016\/j.hroo.2025.11.002_bib10","article-title":"Inappropriate therapy and shock rates between the subcutaneous and transvenous implantable cardiac defibrillator: a secondary analysis of the PRAETORIAN trial","volume":"17","author":"Nordkamp","year":"2024","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hroo.2025.11.002_bib11","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1056\/NEJMsb1609216","article-title":"Real-world evidence- what is it and what can it tell us?","volume":"375","author":"Sherman","year":"2016","journal-title":"N Eng J Med"},{"key":"10.1016\/j.hroo.2025.11.002_bib12","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1016\/j.jacc.2015.02.047","article-title":"Safety and efficacy of the totally subcutaneous implantable defibrillator: 2-year results from a pooled analysis of the IDE study and EFFORTLESS Registry","volume":"65","author":"Burke","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hroo.2025.11.002_bib13","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1111\/jce.12343","article-title":"Which patients are not suitable for a subcutaneous ICD: incidence and predictors of failed QRS-T-wave morphology screening","volume":"25","author":"Nordkamp","year":"2014","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.hroo.2025.11.002_bib14","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.124.010822","article-title":"Quality of life in subcutaneous or transvenous implantable cardioverter-defibrillator patients: a secondary analysis of the PRAETORIAN trial","volume":"17","author":"Knops","year":"2024","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.hroo.2025.11.002_bib15","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1161\/CIRCULATIONAHA.113.003042","article-title":"Safety and efficacy of a totally subcutaneous implantable- cardioverter defibrillator","volume":"128","author":"Weiss","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.hroo.2025.11.002_bib16","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/jce.12612","article-title":"A new algorithm to reduce inappropriate therapy in the S-ICD system","volume":"26","author":"Brisbane","year":"2015","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.hroo.2025.11.002_bib17","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1016\/j.hrthm.2018.05.011","article-title":"Prospective blinded evaluation of a novel sensing methodology designed to reduce inappropriate shocks by the subcutaneous implantable cardioverter-defibrillator","volume":"15","author":"Theuns","year":"2018","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hroo.2025.11.002_bib18","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1093\/europace\/euac202","article-title":"Sense-B-noise: an enigmatic cause for inappropriate shocks in subcutaneous implantable cardioverter defibrillators","volume":"25","author":"Haeberlin","year":"2023","journal-title":"Europace"},{"key":"10.1016\/j.hroo.2025.11.002_bib19","first-page":"1","article-title":"Incidence, implications, and management of sense-B-noise failure in subcutaneous cardioverter-defibrillator patients: insight from a large multicentre registry","volume":"26","author":"W\u00f6rmann","year":"2024","journal-title":"Europace"},{"key":"10.1016\/j.hroo.2025.11.002_bib20","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.joa.2016.05.006","article-title":"Inappropriate shocks from a subcutaneous implantable cardioverter-defibrillator due to oversensing during periods of rate-related bundle branch block","volume":"33","author":"Sousa","year":"2017","journal-title":"J Arrhythm"},{"key":"10.1016\/j.hroo.2025.11.002_bib21","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1056\/NEJMoa2206485","article-title":"Efficacy and safety of an extravascular implantable cardioverter-defibrillator","volume":"387","author":"Friedman","year":"2022","journal-title":"N Eng J Med"},{"key":"10.1016\/j.hroo.2025.11.002_bib22","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1016\/j.jacep.2024.02.033","article-title":"Extravascular implantable cardioverter-defibrillator sensing and detection in a large global population","volume":"10","author":"Swerdlow","year":"2024","journal-title":"JACC Clin Electrophysiol"}],"container-title":["Heart Rhythm O2"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S266650182500532X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S266650182500532X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T11:49:12Z","timestamp":1773920952000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S266650182500532X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S266650182500532X"],"URL":"https:\/\/doi.org\/10.1016\/j.hroo.2025.11.002","relation":{},"ISSN":["2666-5018"],"issn-type":[{"value":"2666-5018","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inappropriate shocks from subcutaneous and transvenous implantable cardioverter-defibrillators: Reports from the FDA MAUDE database","name":"articletitle","label":"Article Title"},{"value":"Heart Rhythm O2","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hroo.2025.11.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Heart Rhythm Society. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}